The singer-songwriter on his evolving solo career, the misguided side of fandom, and how he has never fallen out with his ...

DOMINANT PARTY. Speaker Ferdinand Martin G. Romualdez 'rallies the full political machinery of Lakas-Christian Muslim Democrats (Lakas-CMD) to secure a sweeping victory for the 11-member senatorial ...

A jubilant Mikel Arteta said the momentum is with Arsenal to win the Champions League following their historic victory ...

UNITED STATES – Pfizer is ending the development of its potential once-daily pill treatment for obesity after venturing into the biggest and most expensive level of clinical testing. The ...

Danuglipron, a weight-loss pill, won’t continue its stages of testing after a person in a clinical trial was reportedly injured. Pfizer plans to explore other obesity treatments for testing.

Several companies are working on potentially more convenient GLP-1 pills, including Lilly, which is expected to announce Phase 3 trial results for its drug orforglipron any day now.

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and most expensive level of clinical testing. The drugmaker said Tuesday ...

(AP Photo/Yuki Iwamura) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing ...

Pfizer is halting development of its experimental weight-loss pill, as the booming obesity drug market remains out of reach for the drug giant. The company said Monday the stoppage comes after it ...

Read full article: National Drug Take Back Day gives you a chance to dispose of unused meds Read full article: Jacksonville woman says she feels ‘defeated’ as she struggles to secure her REAL ...

Pfizer signage is displayed at the Pfizer NYC Headquarters, Thursday, April 10, 2025, in New York. (AP Photo/Yuki Iwamura) (Yuki Iwamura, Copyright 2025 The ...